Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Interleukin-based therapy for Stroke: IL-17 inhibits cerebral ischemia induced injury via down regulation of its target gene, 23/January/2015, 23.40, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that IL-17, by suppressing the expression of its target gene, it may inhibit cerebral ischemia induced injury. Thus, pharmacological formulations encompassing “IL-17 activators“ may be used to inhibit cerebral ischemia induced injury.
Amount: $ 300
Undisclosed information: How IL-17 inhibits cerebral ischemia induced injury
Courtesy: When you cite drop us a line at firstname.lastname@example.org